Want to join the conversation?
Life science technology company $VIVO said that it acquired Magellan Biosciences, Inc. and its wholly owned subsidiary Magellan Diagnostics, Inc. The company expects Magellan to contribute to EPS during calendar 2H17. $VIVO will finance the purchase price of $66MM using a combination of cash on hand and a $60MM five-year term loan.
$DB is going to cut off services for about 3,400 clients in equities trading.
$F stock slid more than 2% after the company issued two safety recalls involving more than 650,000 Ford Fusion and Lincoln MKZ model cars.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.
$TSLA opening a showroom in Michigan. A bold move !!